CytoMed Therapeutics
GDTC
#9569
Rank
NZ$41.81 M
Marketcap
$3.62
Share price
-6.19%
Change (1 day)
-47.50%
Change (1 year)

Market capitalization of CytoMed Therapeutics (GDTC)

Market cap: NZ$41.81 Million

As of November 2024 CytoMed Therapeutics has a market cap of NZ$41.81 Million. This makes CytoMed Therapeutics the world's 9569th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CytoMed Therapeutics from 2023 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$41.81 M-53.19%
2023NZ$89.33 M

End of Day market cap according to different sources

On Nov 13th, 2024 the market cap of CytoMed Therapeutics was reported to be:

NZ$44.57 Million
by Nasdaq info icon info icon
NZ$43.78 Million
by CompaniesMarketCap info icon info icon